Comprehensive analysis of transcriptomic, proteomic, and other omics datasets, with interpretation grounded in biological and translational relevance.

Comparative evaluation of diagnostic tools and assay workflows, including performance interpretation and communication of real-world impact.

Discovery and prioritization of biomarkers from omics and clinical data to support diagnostics, stratification, and therapeutic development.

Scientific and regulatory support for early-stage companies, including SOP development, technical documentation, translational positioning, and
scientific narrative building.

Design support for academically rigorous, industry-relevant studies across translational and disease-focused research programs.

Clear, polished support for manuscripts, figures, slide decks, abstracts, and other materials that communicate complex biomedical
data effectively.